Showing results (401-410 of 687) with videos related to
Sort By:
Pageof 69
Atherosclerosis|October 15, 2020
Pulse wave velocity, augmentation index, and carotid intima-media thickness are each associated with different inflammatory protein signatures in young healthy adults: The lifestyle, biomarkers and atherosclerosis studyPaul Pettersson-Pablo, Yang Cao, Lars H Breimer, et al.Current Pharmaceutical Design|December 7, 2010
Chronic hepatitis C, insulin resistance and vascular diseaseAndreja Trpkovic, Edith Stokic, Djordje Radak, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 12, 2005
Effect of antihypertensive treatment on plasma fibrinogen and serum HDL levels in patients with essential hypertensionJohn A Papadakis, Dimitri P Mikhailidis, George E Vrentzos, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 29, 2010
The role of polyphenols in cardiovascular diseaseMarta Michalska, Anna Gluba, Dimitri P Mikhailidis, et al.Rheumatology International|April 15, 2010
Platelet function in rheumatoid arthritis: arthritic and cardiovascular implicationsArmen Yuri Gasparyan, Antonios Stavropoulos-Kalinoglou, Dimitri P Mikhailidis, et al.Current Pharmaceutical Design|November 8, 2017
Effect of Metformin on Plasma Fibrinogen Concentrations: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled TrialsLuis E Simental-Mendia, Matteo Pirro, Stephen L Atkin, et al.Archives of Medical Science : AMS|July 14, 2022
Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (n = 355,591) and randomized controlled trials (n = 165,988)Maciej Banach, Niloofar Shekoohi, Dimitri P Mikhailidis, et al.Journal of Physiology and Biochemistry|July 24, 2010
Effects of L-canavanine and ozone on vascular reactivity in septicemic ratsMohamed A Haidara, Mohamed D Morsy, Hesham A Abdel-Razek, et al.Metabolism: Clinical and Experimental|June 2, 2012
11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?Panagiotis Anagnostis, Niki Katsiki, Fotini Adamidou, et al.Current Pharmaceutical Design|January 5, 2013
PCSK9 inhibition - a novel mechanism to treat lipid disorders?Maciej Banach, Manfredi Rizzo, Milan Obradovic, et al.Pageof 69